Evidence map›Paper›PMID 33506029›Full record

ArticleBioMed research international2021

Radiomics Analysis of MR Imaging with Gd-EOB-DTPA for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma: Investigation and Comparison of Different Hepatobiliary Phase Delay Times.

Shuai Zhang, Guizhi Xu, Chongfeng Duan, Xiaoming Zhou, Xin Wang, Haiyang Yu, Lan Yu, Zhiming Li, Yuanxiang Gao, Ruirui Zhao and 2 more

Abstract read
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. [Research progress of radiomics in the evaluation of microvascular invasion in hepatocellular carcinoma].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
  8. [Research progress of microvascular invasion in hepatocellular carcinoma].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2022
    Review
  9. [Research progress in radiomics based on CT and MRI images for prediction of microvascular invasion in hepatocellular carcinoma].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shuai ZhangDepartment of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Guizhi XuDepartment of Radiology, Zhucheng People Hospital, Zhucheng Shandong, China.
Chongfeng DuanDepartment of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Xiaoming ZhouDepartment of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China.ORCID https://orcid.org/0000-0001-7173-0092
Xin WangDepartment of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Haiyang YuDepartment of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Lan YuDepartment of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Zhiming LiDepartment of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Yuanxiang GaoDepartment of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Ruirui ZhaoOperating Room, The Affiliated Hospital of Qingdao University, Qingdao, China.
Linlin JiaoInterventional department, The Affiliated Hospital of Qingdao University, Qingdao, China.
Gang WangDepartment of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China.ORCID https://orcid.org/0000-0002-1503-919X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate whether the radiomics analysis of MR imaging in the hepatobiliary phase (HBP) can be used to predict microvascular invasion (MVI) in patients with hepatocellular carcinoma (HCC).

methodA total of 130 patients with HCC, including 80 MVI-positive patients and 50 MVI-negative patients, who underwent MR imaging with Gd-EOB-DTPA were enrolled. Least absolute shrinkage and selection operator (LASSO) regression was applied to select radiomics parameters derived from MR images obtained in the HBP 5 min, 10 min, and 15 min images. The selected features at each phase were adopted into support vector machine (SVM) classifiers to establish models. Multiple comparisons of the AUCs at each phase were performed by the Delong test. The decision curve analysis (DCA) was used to analyze the classification of MVI-positive and MVI-negative patients.

resultsThe most predictive features between MVI-positive and MVI-negative patients included 9, 8, and 14 radiomics parameters on HBP 5 min, 10 min, and 15 min images, respectively. A model incorporating the selected features produced an AUC of 0.685, 0.718, and 0.795 on HBP 5 min, 10 min, and 15 min images, respectively. The predictive model for HBP 5 min, 10 min and 15 min showed no significant difference by the Delong test. DCA indicated that the predictive model for HBP 15 min outperformed the models for HBP 5 min and 10 min.

conclusionsRadiomics parameters in the HBP can be used to predict MVI, with the HBP 15 min model having the best differential diagnosis ability.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsNeovascularization, PathologicAgedDiagnosis, DifferentialFemaleGadolinium DTPAHumansLiverMagnetic Resonance ImagingMaleMicrovesselsMiddle AgedRadiographic Image Interpretation, Computer-AssistedRetrospective StudiesGadolinium DTPAgadolinium ethoxybenzyl DTPA

Identifiers

PMID33506029
PMCPMC7810556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.